Year: 2018
Type: article
Abstract: Asthma is a chronic airway inflammatory disorder characterised by airway hyperresponsiveness, inflammation and remodelling, including airway smooth muscle cell (ASMC) hyperplasia and subepithelial airway fibrosis [1, 2]. ASMCs from severe asthmatics are hyperproliferative, release more pro-inflammatory cytokines and are corticosteroid-insensitive compared with those from healthy individuals and non-severe asthma patients [3, 4]. Genetic and epigenetic processes such as miRNA expression and DNA methylation have been implicated in asthma pathogenesis [5]. Indeed, DNA methylation is altered in asthmatic blood cells [5] and may be a biomarker of atopy [6]. Abnormal DNA methylation patterns distinguish airway smooth muscle cell function in asthma and asthma severity <http://ow.ly/cTrK30iCwVK>
Source: European Respiratory Journal
Authors: Mark M. Perry, Paul Lavender, Chih-hsi Scott Kuo, Francesca Galea, Charalambos Michaeloudes, James M. Flanagan, Kian Fan Chung, Ian M. Adcock
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,917
OpenAlex ID: W2789172579
